Antiphospholipid syndrome is an autoimmune disorder characterized by vascular
thrombosis and/or pregnancy morbidity associated with persistent antiphospholipid antibody …

Antiphospholipid syndrome (APS) is an autoantibody-mediated acquired thrombophilia. It is
characterized by the presence of antiphospholipid antibodies (APL) that are directed against …

Objective Recently, our group conceived a risk score for clinical manifestations of APS (the
global APS score, or GAPSS) that takes into account the combination of independent …

Objectives Extra-criteria manifestations of antiphospholipid syndrome (APS) might impact on
prognosis and morbidity of the disease. In this study, we aimed to evaluate a population of …

Background Antiphospholipid syndrome (APS) is an acquired hypercoagulable condition
associated with antiphospholipid antibody (aPL) presence. Data on re-thrombosis following …

Background and aims Cardiovascular disease (CVD), including coronary artery disease and
stroke/peripheral artery disease, is less commonly reported than venous thromboembolism …

Objective To evaluate the subsequent rate of thrombosis among women with obstetric
antiphospholipid syndrome (Ob‐APS) in a multicentre database of antiphospholipid …

Abstract The adjusted Global Antiphospholipid Syndrome (APS) Score (aGAPSS) is a tool
proposed to quantify the risk for antiphospholipid antibody (aPL)-related clinical …

Objectives The antiphospholipid syndrome (APS) is an autoimmune disease associated with
thrombotic and non-thrombotic neurologic manifestations. APS is classified as primary …

Objective To assess the effect of the average adjusted global APS score (aGAPSS) over
time on recurrence of clinical manifestations in APS patients through a retrospective …